Membrane Permeating Macrocycles: Design Guidelines from Machine Learning.


Journal

Journal of chemical information and modeling
ISSN: 1549-960X
Titre abrégé: J Chem Inf Model
Pays: United States
ID NLM: 101230060

Informations de publication

Date de publication:
10 10 2022
Historique:
pubmed: 1 10 2022
medline: 12 10 2022
entrez: 30 9 2022
Statut: ppublish

Résumé

The ability to predict cell-permeable candidate molecules has great potential to assist drug discovery projects. Large molecules that lie beyond the Rule of Five (bRo5) are increasingly important as drug candidates and tool molecules for chemical biology. However, such large molecules usually do not cross cell membranes and cannot access intracellular targets or be developed as orally bioavailable drugs. Here, we describe a random forest (RF) machine learning model for the prediction of passive membrane permeation rates developed using a set of over 1000 bRo5 macrocyclic compounds. The model is based on easily calculated chemical features/descriptors as independent variables. Our random forest (RF) model substantially outperforms a multiple linear regression model based on the same features and achieves better performance metrics than previously reported models using the same underlying data. These features include: (1) polar surface area in water, (2) the octanol-water partitioning coefficient, (3) the number of hydrogen-bond donors, (4) the sum of the topological distances between nitrogen atoms, (5) the sum of the topological distances between nitrogen and oxygen atoms, and (6) the multiple molecular path count of order 2. The last three features represent molecular flexibility, the ability of the molecule to adopt different conformations in the aqueous and membrane interior phases, and the molecular "chameleonicity." Guided by the model, we propose design guidelines for membrane-permeating macrocycles. It is anticipated that this model will be useful in guiding the design of large, bioactive molecules for medicinal chemistry and chemical biology applications.

Identifiants

pubmed: 36178379
doi: 10.1021/acs.jcim.2c00809
doi:

Substances chimiques

Macrocyclic Compounds 0
Octanols 0
Water 059QF0KO0R
Hydrogen 7YNJ3PO35Z
Nitrogen N762921K75
Oxygen S88TT14065

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4605-4619

Auteurs

Billy J Williams-Noonan (BJ)

School of Engineering, RMIT University, Melbourne3001, Australia.
Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville3052, Australia.

Melissa N Speer (MN)

University of Melbourne, Faculty of Engineering and Information Technology, Carlton3053, Australia.

Tu C Le (TC)

School of Engineering, RMIT University, Melbourne3001, Australia.

Maiada M Sadek (MM)

Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville3052, Australia.

Philip E Thompson (PE)

Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville3052, Australia.

Raymond S Norton (RS)

Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville3052, Australia.
ARC Centre for Fragment-Based Design, Monash University, Parkville, 3052, Australia.

Elizabeth Yuriev (E)

Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville3052, Australia.

Nicholas Barlow (N)

Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville3052, Australia.

David K Chalmers (DK)

Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville3052, Australia.

Irene Yarovsky (I)

School of Engineering, RMIT University, Melbourne3001, Australia.

Articles similaires

Exploring blood-brain barrier passage using atomic weighted vector and machine learning.

Yoan Martínez-López, Paulina Phoobane, Yanaima Jauriga et al.
1.00
Blood-Brain Barrier Machine Learning Humans Support Vector Machine Software

Understanding the role of machine learning in predicting progression of osteoarthritis.

Simone Castagno, Benjamin Gompels, Estelle Strangmark et al.
1.00
Humans Disease Progression Machine Learning Osteoarthritis
Animals Dietary Fiber Dextran Sulfate Mice Disease Models, Animal
Silicon Dioxide Water Hot Temperature Compressive Strength X-Ray Diffraction

Classifications MeSH